Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic polymorphisms and atrial fibrillation: Insights into the prothrombotic state and thromboembolic risk.

Annals of medicine - 1 Dec 2010

López-Cuenca Angel, Marín Francisco, Roldán Vanessa, González-Conejero Rocío, Hernández-Romero Diana, Valdés Mariano, Lip Gregory Y H

Abstract excerpt

The pathophysiology of thromboembolism in atrial fibrillation (AF) is a multifactorial and complex process. Abnormalities of haemostasis, fibrinolysis, endothelium, and platelets have all been described in AF. This prothrombotic state observed in AF appears to be additive to the presence of clinical and echocardiography risk factors for thromboembolism. Nonetheless, the precise mechanistic pathway(s) leading to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Atrial Fibrillation
Share to Polymorphism, Single Nucleotide

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Risk Factors

Share to Stroke

Share to Thromboembolism

Share to Thrombophilia

Source

Identifiers

PMID: 20681943
DOI: 10.3109/07853890.2010.507601

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic polymorphisms and atrial fibrillation: Insights into the prothrombotic state and thromboembolic risk.PMID 20681943Read ↗

Pharmacogenetics of antithrombotic drugs.Semantic proximity Read ↗

Atrial fibrillation and hypercoagulability: dependent on clinical factors or/and on genetic alterations?Semantic proximity Read ↗

Pharmacogenetics and oral antithrombotic drugs.Semantic proximity Read ↗

Gene polymorphism as a cause of hemorrhagic complications in patients with non-valvular atrial fibrillation treated with oral vitamin K-independent anticoagulants.Semantic proximity Read ↗

The future prospects of pharmacogenetics in oral anticoagulation therapySemantic proximity Read ↗

Thrombophilic mutations in high-risk atrial fibrillation patients: high prevalence of prothrombin gene G20210A polymorphism and lack of correlation with thromboembolism.Semantic proximity Read ↗

Optimization of anticoagulation with warfarin for stroke prevention: pharmacogenetic considerations.Semantic proximity Read ↗

Pharmacogenetics of Novel Oral Anticoagulants: A Review of Identified Gene Variants & Future PerspectivesSemantic proximity Read ↗

Genetic susceptibility to hemorrhagic complications during warfarin therapy.Semantic proximity Read ↗

Investigating warfarin variability : the contribution of clinical, genetic, and environmental factorsSemantic proximity Read ↗

The Role of Pharmacogenetics in Antithrombotic Therapy Management: New Achievements and Barriers Yet to OvercomeSemantic proximity Read ↗

Pharmacogenetics in Oral Antithrombotic Therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.